Novartis AG
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.
Did you know?
Profit margin of 23.9% — that's well above average.
Current Price
$146.57
-0.87%GoodMoat Value
$194.53
32.7% undervaluedProfile
Valuation (TTM)
Market Cap$279.68B
P/E20.66
EV—
P/B6.06
Shares Out1.91B
P/Sales4.94
Revenue$56.58B
EV/EBITDA11.41
Novartis AG (NVS) Stock News
NVS Stock News & Headlines
Latest stock news and headlines for Novartis AG (NVS). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $146.57. Market cap: $279.68B. Sector: Healthcare. Industry: Drug Manufacturers - General. This page aggregates the latest news articles relevant to NVS from financial news sources, helping investors stay current on events that may impact Novartis AG's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Novartis AG (NVS).